NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Capillary versus venous bedside blood glucose estimations.

Author(s): Boyd R, Leigh B, Stuart P

Publication: Emerg Med J, 2005, Vol. 22, Page 177-9

PubMed ID: 15735263 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of using venous versus capillary blood and using a bedside blood glucometer versus a laboratory multichannel analyzer for the measurement of blood glucose levels.

Conclusion of Paper

Despite very strong correlations between all three glucose measurements, the average blood glucose measured in the laboratory using a venous specimen was significantly lower than the average capillary or venous blood glucose measured using a bedside glucometer. In addition, the average bedside venous blood glucose measurement was significantly higher than the average bedside capillary blood glucose measurement.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of using venous versus capillary blood and using a bedside blood glucometer versus a laboratory multichannel analyzer for the measurement of blood glucose levels. Capillary and venous blood specimens were collected simultaneously and glucose was measured at bedside using each. Half of the venous specimen was sent to the laboratory in a lithium heparin tube for further whole blood glucose estimation.

    Summary of Findings:

    Despite very strong correlations between all three glucose measurements, the average blood glucose measured in the laboratory on a venous specimen by the Dade-Behring Multichannel Analyzer (7.075 mmol/L) was significantly lower than the average capillary (7.66 mmol/L) or venous blood glucose (7.99 mmol/L) measured using a bedside Medisense Precision Plus Glucometer (both p<0.001). In addition, the average bedside venous blood glucose measurement was significantly higher than the average bedside capillary blood glucose measurement (p<0.05).

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    Carbohydrate Clinical chemistry/auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Clinical chemistry/auto analyzer Specific Technology platform Dade-Behring Multichannel Analyzer
    Medisense Precision Plus Glucometer
    Biospecimen Acquisition Anatomical location of blood draw Capillary
    Vein

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...